The USMLE moves to designated testing dates in January 2029. Most of the commentary has been about scheduling. There is a smaller, more practical consequence that nobody has written about, which is what it does to the way study resources are sold.
Access periods assume a flexible date
Question bank subscriptions are priced in fixed terms: a number of months, from the day you activate. That model was built around year-round testing, where your exam sits wherever you put it and you buy roughly enough time to reach it.
Under designated dates, exam dates become discrete. If your preparation runs long, you do not slip by two weeks. You move to the next window, which may be considerably further out, and your subscription does not move with you.
That turns the end date of your access from an afterthought into something worth choosing deliberately.
Buy against the window after your target
The rule that follows is simple. Do not buy a term that ends on your target exam date. Buy one that covers the window after it.
The cost difference between a six-month and a nine-month term is usually modest. The cost of discovering in your final fortnight that access expires before a rescheduled sitting is not, because extending late is consistently the worst-value way to buy time. Short extensions are priced per month at a premium, and they are bought under pressure.
Check the extension terms before you buy
Almost nobody reads this before purchasing, and it is the clause that matters under a fixed calendar. Specifically: can you extend, at what price, and does extending preserve your performance history and your accumulated review queue.
That last part is the one people miss. A subscription that lapses and is repurchased may reset your analytics, which means losing the record of what you have already got wrong. For a bank whose value is in the review loop, that is the expensive part rather than the access itself.
Resist buying a second bank
Fixed dates create a specific temptation. Preparation runs long, the window slips, you now have more time than planned, and buying a second question bank feels like using it well.
It usually is not. A second bank resets you into a new interface with no accumulated analytics, and the extra time is nearly always better spent on the review queue you already have. The gap between finishing one bank thoroughly and sampling two is larger than the gap between any two banks.
If you genuinely finish one with time remaining, a second is worth considering as a source of fresh questions rather than a second full pass.
What to check in a trial
Since the end date now matters, add two questions to the usual ones about explanation quality.
How long is the access period from activation, and does it start when you buy or when you first log in? The difference is a few weeks, which under a fixed calendar can be the difference between covered and not.
What happens to your data if access lapses and resumes? Banks that keep your performance history across a gap are worth more under a model where gaps are more likely.
QBankly is built around that review history rather than question volume, which is the part worth protecting when a date slips. Whichever you choose, the check is the same: read the access terms before you need them.
Nothing urgent
This is a 2029 change and today’s subscriptions are unaffected. It is worth knowing now only because the habit it rewards, buying for the window after your target rather than the one that ends on it, costs nothing to adopt early.
Frequently asked questions
Should I buy a longer subscription than I think I need?
Buy to cover your target date plus the next plausible window. The cost of a slightly longer term is small next to re-subscribing at short notice.
Does this change which bank to choose?
Rarely. It changes the term you buy and how carefully you check what happens if you need to extend, which most people never read before purchasing.